Title: Stage I TNBC: Systemic Therapy Controversies and Future Directions
Speaker: Roberto A. Leon-Ferre, MD

Title: Expanding Clinical Research Access with Decentralized Approaches
Speaker: Tufia C. Haddad, MD

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to: 

1. Examine the existing literature on optimal systemic therapy regimens and duration for Stage I TNBC
2. Debate the optimal sequence of therapeutic modalities for Stage I TNBC
3. Review potential future approaches integrating tissue, blood, and imaging biomarkers for systemic therapy selection in TNBC
4. List various capabilities to decentralize clinical research
5. Describe the benefits of decentralized clinical trials
6. Demonstrate an understanding of the FDA guidance on decentralized clinical trials

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity.  This course is not approved for on-demand delivery. 

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.